MEDIA

16 November 2018

Double nomination at the Bionow Awards

AMLo Biosciences has been shortlisted in two categories at the Bionow 2018 Awards: Project of the Year and Healthcare Project of the Year.

Its hugely rewarding to be shortlisted for the two Bionow awards” remarked AMLo Chief Scientific Officer, Professor Penny Lovat. “Our intense program of discovery and translational research has led to the production of a new melanoma biomarker test which will aid accurate diagnosis, prognosis and care and ultimately patient outcome.”

The Bionow Awards Dinner is “a highlight of the life sciences calendar and celebrates the world-class scientists and companies that are driving the North of England’s life science sector”.

Members of the AMLo team will attend the awards ceremony on 29 November as well as the Bright Ideas in Health Awards, which are being held the same day.

Read the full Bionow announcement of categories and nominations here.

@Bionow #BionowAwards18

 

1 November 2018

Our research is gaining recognition

AMLo Biosciences has been shortlisted in the Development of a Device or Technology category of the Bright Ideas in Health Awards 2018, AMLo Biosciences’ CEO, Dr Marie Labus, said “We are delighted to be shortlisted for this prestigious award. Our 8 years of rigorous research into melanoma biomarker discovery and validation will improve patient outcomes, as well as savings to the NHS, and it’s hugely rewarding to be recognised for this.”

Winners to be announced at the Bright Ideas in Health Awards ceremony, being held on Thursday 29th November at the Hilton Newcastle Gateshead Hotel. @BIHA2018 #BIHA2018

8 October 2018

Funding milestone

Breakthrough cancer test developed in Newcastle gets financial backing.

LINK: https://www.chroniclelive.co.uk/business/business-news/breakthrough-cancer-test-developed-newcastle-15267338

17 January 2018

NICE acknowledgment

The academic founders of AMLo Biosciences have recently been awarded the very first NICEAdviseMe prize for the AMBLor test.

LINK: https://www.nice.org.uk/news/article/newcastle-university-wins-first-nice-adviseme-prize

AMLo Biosciences Limited is a company registered in England and Wales. Company # 11004534

Trading address: Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom

Registered address: c/o RMT Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle upon Tyne, NE12 8EG, United Kingdom

VAT # 285288950

Sign up for our newsletter